Drug treatment of glaucoma.
D000086:Acetazolamide / Q000627:therapeutic use; D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D013759:Dronabinol / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007741:Labetalol / Q000627:therapeutic use; D008916:Miotics / Q000627:therapeutic use; D009248:Nadolol; D010277:Parasympathomimetics / Q000627:therapeutic use; D010862:Pilocarpine / Q000627:therapeutic use; D011412:Propanolamines / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use; D013999:Timolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D008916:Miotics; D010277:Parasympathomimetics; D011412:Propanolamines; D013566:Sympathomimetics; D010862:Pilocarpine; D001971:Bromocriptine; D009248:Nadolol; D013759:Dronabinol; D013999:Timolol; D003000:Clonidine; D000086:Acetazolamide; D007741:Labetalol; D004837:Epinephrine